stoxline Quote Chart Rank Option Currency Glossary
  
Pfizer Inc. (PFE)
27.66  -0.37 (-1.32%)    06-12 16:01
Open: 28.17
High: 28.2299
Volume: 26,658,715
  
Pre. Close: 28.03
Low: 27.56
Market Cap: 156,738(M)
Technical analysis
2024-06-12 4:24:19 PM
Short term     
Mid term     
Targets 6-month :  33.64 1-year :  34.72
Resists First :  28.8 Second :  29.72
Pivot price 28.64
Supports First :  27.31 Second :  22.73
MAs MA(5) :  28.22 MA(20) :  28.65
MA(100) :  27.46 MA(250) :  30.68
MACD MACD :  0.1 Signal :  0.3
%K %D K(14,3) :  14.7 D(3) :  27.4
RSI RSI(14): 43.4
52-week High :  40.36 Low :  25.2
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PFE ] has closed above bottom band by 9.8%. Bollinger Bands are 8.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 28.41 - 28.69 28.69 - 28.85
Low: 26.98 - 27.34 27.34 - 27.55
Close: 27.25 - 27.82 27.82 - 28.17
Company Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Headline News

Wed, 12 Jun 2024
Pfizer Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Wed, 12 Jun 2024
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know - Yahoo Movies UK

Wed, 12 Jun 2024
Pfizer, Flagship to collaborate on obesity drug discovery (NYSE:PFE) - Seeking Alpha

Wed, 12 Jun 2024
Pfizer Inc. (NYSE:PFE) Shares Sold by Cresset Asset Management LLC - Defense World

Tue, 11 Jun 2024
Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch

Tue, 11 Jun 2024
Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Shares Out 5,670 (M)
Shares Float 5,660 (M)
Held by Insiders 0 (%)
Held by Institutions 68.5 (%)
Shares Short 70,220 (K)
Shares Short P.Month 68,060 (K)
Stock Financials
EPS -0.06
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 16.28
Profit Margin -0.6 %
Operating Margin 31.6 %
Return on Assets (ttm) 0.9 %
Return on Equity (ttm) -0.3 %
Qtrly Rev. Growth -19.5 %
Gross Profit (p.s.) 0
Sales Per Share 9.68
EBITDA (p.s.) 1.69
Qtrly Earnings Growth -43.5 %
Operating Cash Flow 8,580 (M)
Levered Free Cash Flow 3,460 (M)
Stock Valuations
PE Ratio -553.08
PEG Ratio -23.2
Price to Book value 1.69
Price to Sales 2.85
Price to Cash Flow 18.27
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android